Symbols / SYK Stock $327.51 -0.65% Stryker Corporation

Healthcare • Medical Devices • United States • NYQ
SYK (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Kevin A. Lobo
Exch · Country NYQ · United States
Market Cap 125.43B
Enterprise Value 137.59B
Income 3.25B
Sales 25.12B
FCF (ttm) 4.17B
Book/sh 58.61
Cash/sh 10.71
Employees 56,000
Insider 10d
IPO Mar 17, 1980
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 40.48%
P/E 39.08
Forward P/E 19.56
PEG 1.56
P/S 4.99
P/B 5.59
P/C
EV/EBITDA 19.80
EV/Sales 5.48
Quick Ratio 1.04
Current Ratio 1.89
Debt/Eq 72.97
LT Debt/Eq
EPS (ttm) 8.38
EPS next Y 16.74
EPS Growth 55.90%
Revenue Growth 11.40%
EPS Gr Q/Q 55.50%
Rev Gr Q/Q
Earnings (next) 2026-04-30
Earnings (prior) 2026-01-29
ROA 7.92%
ROE 15.08%
ROIC
Gross Margin 65.04%
Oper. Margin 27.23%
Profit Margin 12.92%
Shs Outstand 382.98M
Shs Float 346.55M
Insider Own 5.37%
Instit Own 81.66%
Short Float 1.29%
Short Ratio 2.25
Short Interest 4.72M
52W High 404.87
vs 52W High -19.11%
52W Low 319.32
vs 52W Low 2.56%
Beta 0.93
Impl. Vol. 36.67%
Rel Volume 0.70
Avg Volume 2.07M
Volume 1.44M
Target (mean) $419.11
Tgt Median $420.00
Tgt Low $316.00
Tgt High $469.00
# Analysts 27
Recom Buy
Prev Close $329.65
Price $327.51
Change -0.65%
About

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$327.51
Low
$316.00
High
$469.00
Mean
$419.11

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-15 main Truist Securities Hold → Hold $380
2026-04-14 reit BTIG Buy → Buy $397
2026-04-13 init Leerink Partners — → Outperform $410
2026-04-09 main Goldman Sachs Neutral → Neutral $357
2026-04-07 main Citigroup Buy → Buy $385
2026-04-06 main Evercore ISI Group Outperform → Outperform $365
2026-03-17 main UBS Neutral → Neutral $380
2026-02-24 main UBS Neutral → Neutral $400
2026-01-30 main Needham Buy → Buy $454
2026-01-30 main BTIG Buy → Buy $412
2026-01-09 main Bernstein Outperform → Outperform $465
2025-12-19 up Citizens Market Perform → Market Outperform $440
2025-12-18 main Truist Securities Hold → Hold $392
2025-12-11 main Citigroup Buy → Buy $420
2025-11-14 main Truist Securities Hold → Hold $400
2025-11-14 main Wells Fargo Overweight → Overweight $456
2025-11-14 reit Needham Buy → Buy $448
2025-11-14 reit BTIG Buy → Buy $410
2025-11-03 reit Truist Securities Hold → Hold $392
2025-10-31 main Evercore ISI Group Outperform → Outperform $405
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-20 MENON VIJU S Officer 269
2026-03-20 FLETCHER ROBERT S Officer 225
2026-03-20 PIERCE JAMES ANDREW Officer 430
2026-03-20 STILES SPENCER S President 430
2026-03-20 LOBO KEVIN A Chief Executive Officer 1,452
2026-03-20 FINK MARY KATHRYN Officer 150
2026-03-09 MENON VIJU S Officer 9,320 $0.00 $0
2026-03-09 FLETCHER ROBERT S Officer 7,828 $0.00 $0
2026-03-09 PIERCE JAMES ANDREW Officer 14,912 $0.00 $0
2026-03-09 STILES SPENCER S President 14,912 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
25,116.00
+11.16%
22,595.00
+10.23%
20,498.00
+11.11%
18,449.00
Operating Revenue
25,116.00
+11.16%
22,595.00
+10.23%
20,498.00
+11.11%
18,449.00
Cost Of Revenue
9,051.00
+10.99%
8,155.00
+9.61%
7,440.00
+8.28%
6,871.00
Reconciled Cost Of Revenue
8,590.00
+11.15%
7,728.00
+9.66%
7,047.00
+8.42%
6,500.00
Gross Profit
16,065.00
+11.25%
14,440.00
+10.58%
13,058.00
+12.78%
11,578.00
Operating Expense
11,006.00
+12.60%
9,774.00
+7.01%
9,134.00
+7.88%
8,467.00
Research And Development
1,623.00
+10.71%
1,466.00
+5.62%
1,388.00
-4.54%
1,454.00
Selling General And Administration
8,651.00
+12.57%
7,685.00
+8.07%
7,111.00
+11.35%
6,386.00
Total Expenses
20,057.00
+11.87%
17,929.00
+8.18%
16,574.00
+8.06%
15,338.00
Operating Income
5,059.00
+8.42%
4,666.00
+18.91%
3,924.00
+26.13%
3,111.00
Total Operating Income As Reported
4,889.00
+32.53%
3,689.00
-5.12%
3,888.00
+36.85%
2,841.00
EBITDA
6,314.00
+27.53%
4,951.00
-2.23%
5,064.00
+23.24%
4,109.00
Normalized EBITDA
6,484.00
+9.38%
5,928.00
+16.24%
5,100.00
+16.46%
4,379.00
Reconciled Depreciation
1,193.00
+13.62%
1,050.00
+2.14%
1,028.00
+3.01%
998.00
EBIT
5,121.00
+31.27%
3,901.00
-3.34%
4,036.00
+29.73%
3,111.00
Total Unusual Items
-170.00
+82.60%
-977.00
-2613.89%
-36.00
+86.67%
-270.00
Total Unusual Items Excluding Goodwill
-170.00
+82.60%
-977.00
-2613.89%
-36.00
+86.67%
-270.00
Special Income Charges
-170.00
+82.60%
-977.00
-2613.89%
-36.00
+86.67%
-270.00
Other Special Charges
18.00
+220.00%
-15.00
Impairment Of Capital Assets
170.00
-82.60%
977.00
+2613.89%
36.00
-86.67%
270.00
Net Income
3,246.00
+8.45%
2,993.00
-5.43%
3,165.00
+34.22%
2,358.00
Pretax Income
4,514.00
+29.27%
3,492.00
-4.93%
3,673.00
+36.90%
2,683.00
Net Non Operating Interest Income Expense
-607.00
-48.41%
-409.00
-12.67%
-363.00
Interest Expense Non Operating
607.00
+48.41%
409.00
+12.67%
363.00
Net Interest Income
-607.00
-48.41%
-409.00
-12.67%
-363.00
Interest Expense
607.00
+48.41%
409.00
+12.67%
363.00
Other Income Expense
62.00
+108.10%
-765.00
-783.04%
112.00
+126.17%
-428.00
Other Non Operating Income Expenses
232.00
+9.43%
212.00
+43.24%
148.00
+193.67%
-158.00
Tax Provision
1,268.00
+154.11%
499.00
-1.77%
508.00
+56.31%
325.00
Tax Rate For Calcs
0.00
+96.58%
0.00
+3.55%
0.00
+14.05%
0.00
Tax Effect Of Unusual Items
-47.75
+65.80%
-139.61
-2710.21%
-4.97
+84.79%
-32.67
Net Income Including Noncontrolling Interests
3,246.00
+8.45%
2,993.00
-5.43%
3,165.00
+34.22%
2,358.00
Net Income From Continuing Operation Net Minority Interest
3,246.00
+8.45%
2,993.00
-5.43%
3,165.00
+34.22%
2,358.00
Net Income From Continuing And Discontinued Operation
3,246.00
+8.45%
2,993.00
-5.43%
3,165.00
+34.22%
2,358.00
Net Income Continuous Operations
3,246.00
+8.45%
2,993.00
-5.43%
3,165.00
+34.22%
2,358.00
Normalized Income
3,368.25
-12.07%
3,830.39
+19.85%
3,196.03
+23.15%
2,595.33
Net Income Common Stockholders
3,246.00
+8.45%
2,993.00
-5.43%
3,165.00
+34.22%
2,358.00
Diluted EPS
8.40
+8.25%
7.76
-5.94%
8.25
+33.71%
6.17
Basic EPS
8.49
+8.02%
7.86
-5.76%
8.34
+33.87%
6.23
Basic Average Shares
382.20
+0.31%
381.00
+0.37%
379.60
+0.37%
378.20
Diluted Average Shares
386.50
+0.23%
385.60
+0.50%
383.70
+0.39%
382.20
Diluted NI Availto Com Stockholders
3,246.00
+8.45%
2,993.00
-5.43%
3,165.00
+34.22%
2,358.00
Amortization
732.00
+17.50%
623.00
-1.89%
635.00
+1.28%
627.00
Amortization Of Intangibles Income Statement
732.00
+17.50%
623.00
-1.89%
635.00
+1.28%
627.00
Depreciation Amortization Depletion Income Statement
732.00
+17.50%
623.00
-1.89%
635.00
+1.28%
627.00
Depreciation And Amortization In Income Statement
732.00
+17.50%
623.00
-1.89%
635.00
+1.28%
627.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
47,844.00
+11.34%
42,971.00
+7.66%
39,912.00
+8.21%
36,884.00
Current Assets
14,755.00
-0.62%
14,847.00
+18.61%
12,518.00
+21.83%
10,275.00
Cash Cash Equivalents And Short Term Investments
4,100.00
-8.75%
4,493.00
+47.17%
3,053.00
+58.35%
1,928.00
Cash And Cash Equivalents
4,011.00
+9.83%
3,652.00
+22.92%
2,971.00
+61.12%
1,844.00
Other Short Term Investments
89.00
-89.42%
841.00
+925.61%
82.00
-2.38%
84.00
Receivables
4,039.00
+1.30%
3,987.00
+5.90%
3,765.00
+5.61%
3,565.00
Accounts Receivable
4,039.00
+1.30%
3,987.00
+5.90%
3,765.00
+5.61%
3,565.00
Gross Accounts Receivable
4,255.00
+1.31%
4,200.00
+6.41%
3,947.00
+6.13%
3,719.00
Allowance For Doubtful Accounts Receivable
-216.00
-1.41%
-213.00
-17.03%
-182.00
-18.18%
-154.00
Inventory
5,310.00
+11.23%
4,774.00
-1.42%
4,843.00
+21.23%
3,995.00
Raw Materials
1,349.00
+17.61%
1,147.00
-7.65%
1,242.00
+23.46%
1,006.00
Work In Process
415.00
+23.51%
336.00
+1.82%
330.00
-5.17%
348.00
Finished Goods
3,546.00
+7.75%
3,291.00
+0.61%
3,271.00
+23.85%
2,641.00
Prepaid Assets
787.00
Other Current Assets
1,306.00
-18.02%
1,593.00
+85.88%
857.00
+8.89%
787.00
Total Non Current Assets
33,089.00
+17.65%
28,124.00
+2.66%
27,394.00
+2.95%
26,609.00
Net PPE
3,876.00
+12.41%
3,448.00
+7.25%
3,215.00
+8.25%
2,970.00
Gross PPE
7,537.00
+12.78%
6,683.00
+5.34%
6,344.00
+9.29%
5,805.00
Accumulated Depreciation
-3,661.00
-13.17%
-3,235.00
-3.39%
-3,129.00
-10.37%
-2,835.00
Properties
1,793.00
+10.20%
1,627.00
-3.84%
1,692.00
-2.70%
1,739.00
Machinery Furniture Equipment
5,744.00
+13.61%
5,056.00
+8.68%
4,652.00
+14.41%
4,066.00
Goodwill And Other Intangible Assets
24,972.00
+23.32%
20,250.00
+2.09%
19,836.00
+0.36%
19,765.00
Goodwill
19,291.00
+21.67%
15,855.00
+4.01%
15,243.00
+2.44%
14,880.00
Other Intangible Assets
5,681.00
+29.26%
4,395.00
-4.31%
4,593.00
-5.98%
4,885.00
Non Current Deferred Assets
1,098.00
-36.97%
1,742.00
+4.31%
1,670.00
+18.44%
1,410.00
Non Current Deferred Taxes Assets
1,098.00
-36.97%
1,742.00
+4.31%
1,670.00
+18.44%
1,410.00
Other Non Current Assets
3,143.00
+17.10%
2,684.00
+0.41%
2,673.00
+8.48%
2,464.00
Total Liabilities Net Minority Interest
25,424.00
+13.82%
22,337.00
+4.78%
21,319.00
+5.19%
20,268.00
Current Liabilities
7,794.00
+2.34%
7,616.00
-3.85%
7,921.00
+25.67%
6,303.00
Payables And Accrued Expenses
5,199.00
+8.22%
4,804.00
+10.46%
4,349.00
+9.74%
3,963.00
Payables
2,554.00
+0.63%
2,538.00
+14.74%
2,212.00
+11.21%
1,989.00
Accounts Payable
1,799.00
+7.15%
1,679.00
+10.68%
1,517.00
+7.36%
1,413.00
Dividends Payable
337.00
+5.31%
320.00
+5.26%
304.00
+7.04%
284.00
Current Accrued Expenses
2,645.00
+16.73%
2,266.00
+6.04%
2,137.00
+8.26%
1,974.00
Pensionand Other Post Retirement Benefit Plans Current
1,595.00
+13.68%
1,403.00
-5.07%
1,478.00
+28.63%
1,149.00
Total Tax Payable
418.00
-22.45%
539.00
+37.85%
391.00
+33.90%
292.00
Income Tax Payable
418.00
-22.45%
539.00
+37.85%
391.00
+33.90%
292.00
Current Debt And Capital Lease Obligation
1,000.00
-29.03%
1,409.00
-32.71%
2,094.00
+75.82%
1,191.00
Current Debt
1,000.00
-29.03%
1,409.00
-32.71%
2,094.00
+75.82%
1,191.00
Other Current Borrowings
1,000.00
-29.03%
1,409.00
-32.71%
2,094.00
Total Non Current Liabilities Net Minority Interest
17,630.00
+19.76%
14,721.00
+9.87%
13,398.00
-4.06%
13,965.00
Long Term Debt And Capital Lease Obligation
14,859.00
+21.91%
12,188.00
+11.81%
10,901.00
-8.06%
11,857.00
Long Term Debt
14,859.00
+21.91%
12,188.00
+11.81%
10,901.00
-8.06%
11,857.00
Tradeand Other Payables Non Current
402.00
+15.19%
349.00
-38.45%
567.00
-11.54%
641.00
Other Non Current Liabilities
2,369.00
+8.47%
2,184.00
+13.16%
1,930.00
+31.56%
1,467.00
Stockholders Equity
22,420.00
+8.66%
20,634.00
+10.98%
18,593.00
+11.90%
16,616.00
Common Stock Equity
22,420.00
+8.66%
20,634.00
+10.98%
18,593.00
+11.90%
16,616.00
Capital Stock
38.00
+0.00%
38.00
+0.00%
38.00
+0.00%
38.00
Common Stock
38.00
+0.00%
38.00
+0.00%
38.00
+0.00%
38.00
Share Issued
382.50
+0.29%
381.40
+0.34%
380.10
+0.37%
378.70
Ordinary Shares Number
382.50
+0.29%
381.40
+0.34%
380.10
+0.37%
378.70
Additional Paid In Capital
2,597.00
+10.00%
2,361.00
+7.32%
2,200.00
+8.16%
2,034.00
Retained Earnings
20,472.00
+10.49%
18,528.00
+10.48%
16,771.00
+13.59%
14,765.00
Gains Losses Not Affecting Retained Earnings
-687.00
-134.47%
-293.00
+29.57%
-416.00
-88.24%
-221.00
Other Equity Adjustments
-687.00
-134.47%
-293.00
+29.57%
-416.00
-88.24%
-221.00
Total Equity Gross Minority Interest
22,420.00
+8.66%
20,634.00
+10.98%
18,593.00
+11.90%
16,616.00
Total Capitalization
37,279.00
+13.58%
32,822.00
+11.28%
29,494.00
+3.59%
28,473.00
Working Capital
6,961.00
-3.73%
7,231.00
+57.30%
4,597.00
+15.74%
3,972.00
Invested Capital
38,279.00
+11.83%
34,231.00
+8.37%
31,588.00
+6.49%
29,664.00
Total Debt
15,859.00
+16.64%
13,597.00
+4.63%
12,995.00
-0.41%
13,048.00
Net Debt
11,848.00
+19.14%
9,945.00
-0.79%
10,024.00
-10.53%
11,204.00
Net Tangible Assets
-2,552.00
-764.58%
384.00
+130.89%
-1,243.00
+60.53%
-3,149.00
Tangible Book Value
-2,552.00
-764.58%
384.00
+130.89%
-1,243.00
+60.53%
-3,149.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
5,044.00
+18.91%
4,242.00
+14.31%
3,711.00
+41.43%
2,624.00
Cash Flow From Continuing Operating Activities
5,044.00
+18.91%
4,242.00
+14.31%
3,711.00
+41.43%
2,624.00
Net Income From Continuing Operations
3,246.00
+8.45%
2,993.00
-5.43%
3,165.00
+34.22%
2,358.00
Depreciation Amortization Depletion
1,193.00
+13.62%
1,050.00
+2.14%
1,028.00
+3.01%
998.00
Depreciation
461.00
+7.96%
427.00
+8.65%
393.00
+5.93%
371.00
Amortization Cash Flow
732.00
+17.50%
623.00
-1.89%
635.00
+1.28%
627.00
Depreciation And Amortization
1,193.00
+13.62%
1,050.00
+2.14%
1,028.00
+3.01%
998.00
Amortization Of Intangibles
732.00
+17.50%
623.00
-1.89%
635.00
+1.28%
627.00
Other Non Cash Items
173.00
+276.09%
46.00
+370.59%
-17.00
-241.67%
12.00
Stock Based Compensation
243.00
+6.11%
229.00
+11.71%
205.00
+22.02%
168.00
Asset Impairment Charge
170.00
-82.60%
977.00
+2613.89%
36.00
-86.67%
270.00
Deferred Tax
392.00
+205.95%
-370.00
-79.61%
-206.00
-455.17%
58.00
Deferred Income Tax
392.00
+205.95%
-370.00
-79.61%
-206.00
-455.17%
58.00
Change In Working Capital
-373.00
+45.39%
-683.00
-32.11%
-517.00
+58.31%
-1,240.00
Change In Receivables
127.00
+139.56%
-321.00
-83.43%
-175.00
+69.78%
-579.00
Changes In Account Receivables
127.00
+139.56%
-321.00
-83.43%
-175.00
+69.78%
-579.00
Change In Inventory
-297.00
-44.17%
-206.00
+74.15%
-797.00
-4.59%
-762.00
Change In Payables And Accrued Expense
267.00
+78.00%
150.00
-74.53%
589.00
+183.17%
208.00
Change In Accrued Expense
318.00
+329.73%
74.00
-85.66%
516.00
+230.77%
156.00
Change In Payable
-51.00
-167.11%
76.00
+4.11%
73.00
+40.38%
52.00
Change In Account Payable
94.00
-51.04%
192.00
+149.35%
77.00
-73.45%
290.00
Change In Other Working Capital
-470.00
-53.59%
-306.00
-128.36%
-134.00
-25.23%
-107.00
Investing Cash Flow
-4,866.00
-62.20%
-3,000.00
-211.85%
-962.00
+67.10%
-2,924.00
Cash Flow From Continuing Investing Activities
-4,866.00
-62.20%
-3,000.00
-211.85%
-962.00
+67.10%
-2,924.00
Net PPE Purchase And Sale
-761.00
-0.79%
-755.00
-31.30%
-575.00
+2.21%
-588.00
Purchase Of PPE
-761.00
-0.79%
-755.00
-31.30%
-575.00
+2.21%
-588.00
Capital Expenditure
-761.00
-0.79%
-755.00
-31.30%
-575.00
+2.21%
-588.00
Net Investment Purchase And Sale
750.00
+200.00%
-750.00
0.00
-100.00%
188.00
Purchase Of Investment
-808.00
-1453.85%
-52.00
+0.00%
-52.00
Sale Of Investment
148.00
+174.07%
54.00
-77.50%
240.00
Net Business Purchase And Sale
-4,795.00
-194.53%
-1,628.00
-317.44%
-390.00
+84.78%
-2,563.00
Purchase Of Business
-4,960.00
-204.67%
-1,628.00
-317.44%
-390.00
+84.78%
-2,563.00
Net Other Investing Changes
-60.00
-145.11%
133.00
+4333.33%
3.00
-92.31%
39.00
Financing Cash Flow
113.00
+121.52%
-525.00
+67.06%
-1,594.00
-112.82%
-749.00
Cash Flow From Continuing Financing Activities
113.00
+121.52%
-525.00
+67.06%
-1,594.00
-112.82%
-749.00
Net Issuance Payments Of Debt
1,579.00
+67.98%
940.00
+439.35%
-277.00
-158.69%
472.00
Issuance Of Debt
2,979.00
-1.06%
3,011.00
+142.63%
1,241.00
-17.27%
1,500.00
Repayment Of Debt
-1,400.00
+31.34%
-2,039.00
+0.92%
-2,058.00
-215.16%
-653.00
Long Term Debt Issuance
2,979.00
-1.06%
3,011.00
+142.63%
1,241.00
-17.27%
1,500.00
Long Term Debt Payments
-1,400.00
+31.34%
-2,039.00
+0.92%
-2,058.00
-215.16%
-653.00
Net Long Term Debt Issuance
1,579.00
+62.45%
972.00
+218.97%
-817.00
-196.46%
847.00
Net Short Term Debt Issuance
0.00
+100.00%
-32.00
-105.93%
540.00
+244.00%
-375.00
Net Common Stock Issuance
Common Stock Payments
Common Stock Dividend Paid
-1,284.00
-5.33%
-1,219.00
-7.02%
-1,139.00
-8.37%
-1,051.00
Cash Dividends Paid
-1,284.00
-5.33%
-1,219.00
-7.02%
-1,139.00
-8.37%
-1,051.00
Repurchase Of Capital Stock
Net Other Financing Charges
-182.00
+26.02%
-246.00
-38.20%
-178.00
-4.71%
-170.00
Changes In Cash
291.00
-59.41%
717.00
-37.92%
1,155.00
+210.10%
-1,049.00
Effect Of Exchange Rate Changes
68.00
+288.89%
-36.00
-28.57%
-28.00
+45.10%
-51.00
Beginning Cash Position
3,652.00
+22.92%
2,971.00
+61.12%
1,844.00
-37.36%
2,944.00
End Cash Position
4,011.00
+9.83%
3,652.00
+22.92%
2,971.00
+61.12%
1,844.00
Free Cash Flow
4,283.00
+22.83%
3,487.00
+11.19%
3,136.00
+54.03%
2,036.00
Interest Paid Supplemental Data
582.00
+46.97%
396.00
+11.24%
356.00
+9.88%
324.00
Income Tax Paid Supplemental Data
1,002.00
+1.31%
989.00
+42.71%
693.00
+37.23%
505.00
Change In Income Tax Payable
-145.00
-25.00%
-116.00
-2800.00%
-4.00
+98.32%
-238.00
Change In Tax Payable
-145.00
-25.00%
-116.00
-2800.00%
-4.00
+98.32%
-238.00
Sale Of Business
165.00
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category